Basics Applied Therapeutics, Inc. Common Stock IPO Date: May 13, 2019 Sector: Healthcare Industry: Biotech Market Cap: $58.03M Activated in VL: True Average Daily Range Avg Daily Range: $0.46 | 4.25% Avg Daily Range (30 D): $0.03 | 5.98% Avg Daily Range (90 D): $0.03 | 5.58% Institutional Daily Volume Avg Daily Volume: .74M Avg Daily Volume (30 D): 2.25M Avg Daily Volume (90 D): 2.12M Trade Size Avg Trade Size (Sh.): 190 Avg Trade Size (Sh.) (30 D): 412 Avg Trade Size (Sh.) (90 D): 368 Institutional Trades Total Inst.Trades: 405 Avg Inst. Trade: $2.01M Avg Inst. Trade (30 D): $.93M Avg Inst. Trade (90 D): $1.09M Avg Inst. Trade Volume: .36M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.33M Avg Closing Trade (30 D): $1.22M Avg Closing Trade (90 D): $.89M Avg Closing Volume: 392.28K         News May 18, 2025 @ 11:28 AM Applied Therapeutics Presents Full 12-Month Clinic... Source: N/A May 13, 2025 @ 9:00 PM Applied Therapeutics Reports First Quarter 2025 Fi... Source: N/A May 9, 2025 @ 9:00 PM Applied Therapeutics Announces Acceptance of Late-... Source: N/A Apr 14, 2025 @ 9:50 PM Applied Therapeutics Reports Fourth Quarter and Ye... Source: N/A Feb 17, 2025 @ 5:52 PM APLT DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL,... Source: N/A Financials   TTM Q1 2025 Q4 2024 Basic EPS $-.47 $-.15 $.33 Diluted EPS $-.62 $-.15 $.33 Revenue $ .33M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -58.86M $ -21.83M $ 44.01M Operating Income / Loss $ -100.08M $ -25.53M $ -33.02M Cost of Revenue $ $ $ Net Cash Flow $ -28.64M $ -28.64M $ M PE Ratio